drug combination tenofovir alafenamide emtricitabine bictegravir

Also Known As:

bictegravir, emtricitabine, tenofovir alafenamide, drug combination; Biktarvy; bictegravir emtricitabine tenofovir alafenamide; bictegravir emtricitabine tenofovir alafenamide drug combination

Networked: 32 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - Adenine: 2120
        Tenofovir: 2723
        drug combination tenofovir alafenamide emtricitabine bictegravir: 32
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - Cytidine: 535
      - Deoxycytidine: 307
        Emtricitabine: 628
        drug combination tenofovir alafenamide emtricitabine bictegravir: 32
  - Deoxyribonucleosides: 34
    - Deoxycytidine: 307
      - Emtricitabine: 628
        drug combination tenofovir alafenamide emtricitabine bictegravir: 32
Organic Chemicals: 133
- Organophosphorus Compounds: 300
  - Organophosphonates: 424
    - Tenofovir: 2723
      - drug combination tenofovir alafenamide emtricitabine bictegravir: 32
Amino Acids, Peptides, and Proteins: 1
- Amino Acids: 30675
  - Alanine: 4133
    - drug combination tenofovir alafenamide emtricitabine bictegravir: 32
Pharmaceutical Preparations
- Drug Combinations: 5337
  - drug combination tenofovir alafenamide emtricitabine bictegravir: 32

Experts

1.	Deeks, Emma D: 2 articles (01/2019 - 11/2018)
2.	Berenguer, Juan: 1 article (05/2022)
3.	Blair, Christiana: 1 article (05/2022)
4.	Chuck, Susan K: 1 article (05/2022)
5.	D'Antoni, Michelle L: 1 article (05/2022)
6.	De Wit, Stephane: 1 article (05/2022)
7.	Gallant, Joel: 1 article (05/2022)
8.	Haubrich, Richard: 1 article (05/2022)
9.	Maggiolo, Franco: 1 article (05/2022)
10.	Martin, Hal: 1 article (05/2022)

Related Diseases

1.	Infections 01/01/2023 - "Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is an effective treatment for HIV-1 infection; however, clinical trial data in older people living with HIV (PLWH) are lacking. " 01/01/2023 - "Efficacy, safety and tolerability of Biktarvy in HIV-1 infection: A scoping review." 01/01/2019 - "The article Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection, written by Emma D. " 01/01/2019 - "Correction to: Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection." 11/01/2018 - "Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection."
2.	HIV Infections (HIV Infection) 11/01/2023 - "Biktarvy for the treatment of HIV infection: Progress and prospects." 12/01/2021 - "Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection." 07/01/2020 - "We report here a 62-year-old man with diabetes and HIV infection, and receiving Biktarvy for 1 month. " 04/01/2019 - "Bictegravir/emtricitabine/tenofovir alafenamide for HIV infection." 01/01/2023 - "A 56-year-old white female with a history of sleeve gastrectomy was initiated on coformulated bictegravir/emtricitabine/tenofovir alafenamide for treatment of HIV infection. "
3.	Weight Gain 10/01/2023 - "Weight Gain After 12 Months of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV Patients." 09/20/2023 - "Weight gain and metabolic disturbances in people living with HIV who start antiretroviral therapy with, or switch to, bictegravir/emtricitabine/tenofovir alafenamide after 48 weeks of treatment: A real-world prospective study." 09/20/2023 - "The aim of this study was to evaluate the weight gain and metabolic disturbances in PLWH who start antiretroviral therapy (ART) with bictegravir/emtricitabine/tenofovir alafenamide and in individuals who switch from another ART to BIC/FTC/TAF after 48 weeks. " 02/01/2022 - "Body mass index increase and weight gain among people living with HIV-1 initiated on single-tablet darunavir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide in the United States."
4.	Substance-Related Disorders (Drug Abuse) 03/01/2023 - "Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Patients With HIV-1 Infection and Ongoing Substance Use Disorder: The BASE Study."
5.	Pancreatitis 01/01/2020 - "Bictegravir/emtricitabine/tenofovir alafenamide-induced acute pancreatitis: a case report." 07/01/2020 - "Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis."

Related Drugs and Biologics

1.	dolutegravir
2.	Racivir
3.	Darunavir (Prezista)
4.	elvitegravir
5.	imidazole mustard (BIC)
6.	drug combination tenofovir alafenamide emtricitabine bictegravir
7.	bictegravir
8.	Lamivudine (Epivir)
9.	Vinblastine (Vinblastine Sulfate)
10.	Testosterone (Sustanon)

Related Therapies and Procedures

1.	Art Therapy
2.	Therapeutics
3.	Peritoneal Dialysis
4.	Injections
5.	Renal Dialysis (Hemodialysis)